Moonlake Immunotherapeutics Stock Analysis

MoonLake Stock Analysis Notes

About 61.0% of the company shares are owned by institutional investors. The book value of MoonLake Immunotherapeuti was now reported as 4.54. The company recorded a loss per share of 3.33. MoonLake Immunotherapeuti had not issued any dividends in recent years. MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland. Moonlake Immunotherapeuti is traded on NASDAQ Exchange in the United States. To find out more about MoonLake Immunotherapeutics contact Jorge Silva at 41 415108022 or learn more at https://www.moonlaketx.com.

MoonLake Immunotherapeuti Investment Alerts

MoonLake Immunotherapeuti Upcoming and Recent Events

MoonLake Largest EPS Surprises

View All Earnings Estimates

MoonLake Immunotherapeuti Environmental, Social, and Governance (ESG) Scores

MoonLake Stock Institutional Investors

Note, although MoonLake Immunotherapeuti's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

MoonLake Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 791.37 M.

MoonLake Profitablity

Management Efficiency

MoonLake Immunotherapeuti has return on total asset (ROA) of (0.3072) % which means that it has lost $0.3072 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5433) %, meaning that it created substantial loss on money invested by shareholders. MoonLake Immunotherapeuti's management efficiency ratios could be used to measure how well MoonLake Immunotherapeuti manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.24 in 2026. Return On Capital Employed is likely to rise to -0.34 in 2026. At this time, MoonLake Immunotherapeuti's Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 28.3 M in 2026, whereas Non Current Assets Total are likely to drop slightly above 3.1 M in 2026.

Technical Drivers

As of the 7th of January, MoonLake Immunotherapeuti secures the Risk Adjusted Performance of 0.1234, mean deviation of 3.49, and Downside Deviation of 3.92. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of MoonLake Immunotherapeuti, as well as the relationship between them.

MoonLake Immunotherapeuti Price Movement Analysis

MoonLake Immunotherapeuti Insider Trading Activities

MoonLake Immunotherapeuti Outstanding Bonds

MoonLake Immunotherapeuti Predictive Daily Indicators

MoonLake Immunotherapeuti Corporate Filings

MoonLake Immunotherapeuti Forecast Models

MoonLake Immunotherapeuti's time-series forecasting models are one of many MoonLake Immunotherapeuti's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary MoonLake Immunotherapeuti's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

MoonLake Immunotherapeuti Bond Ratings

MoonLake Immunotherapeutics financial ratings play a critical role in determining how much MoonLake Immunotherapeuti have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for MoonLake Immunotherapeuti's borrowing costs.

MoonLake Immunotherapeuti Debt to Cash Allocation

MoonLake Immunotherapeutics currently holds 2.83 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. MoonLake Immunotherapeuti has a current ratio of 25.0, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about MoonLake Immunotherapeuti's use of debt, we should always consider it together with its cash and equity.

MoonLake Immunotherapeuti Total Assets Over Time

MoonLake Immunotherapeuti Assets Financed by Debt

The debt-to-assets ratio shows the degree to which MoonLake Immunotherapeuti uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

MoonLake Immunotherapeuti Debt Ratio

0.65

It appears most of the MoonLake Immunotherapeuti's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the MoonLake Immunotherapeuti's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of MoonLake Immunotherapeuti, which in turn will lower the firm's financial flexibility.

MoonLake Immunotherapeuti Corporate Bonds Issued

MoonLake Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how MoonLake Immunotherapeuti prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MoonLake shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as MoonLake Immunotherapeuti. By using and applying MoonLake Stock analysis, traders can create a robust methodology for identifying MoonLake entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. MoonLake analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. MoonLake analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

MoonLake Immunotherapeutics stock analysis indicators help investors evaluate how MoonLake Immunotherapeuti stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading MoonLake Immunotherapeuti shares will generate the highest return on investment. By understating and applying MoonLake Immunotherapeuti stock analysis, traders can identify MoonLake Immunotherapeuti position entry and exit signals to maximize returns.

When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.